摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(氯甲基)哌啶盐酸盐 | 3947-52-2

中文名称
3-(氯甲基)哌啶盐酸盐
中文别名
——
英文名称
3-chloromethylpiperidine hydrochloride
英文别名
3-(Chloromethyl)piperidine hydrochloride;3-(chloromethyl)piperidine;hydrochloride
3-(氯甲基)哌啶盐酸盐化学式
CAS
3947-52-2
化学式
C6H12ClN*ClH
mdl
——
分子量
170.082
InChiKey
IOFKRVJEAOUXPG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    153-154 °C

计算性质

  • 辛醇/水分配系数(LogP):
    1.65
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    12
  • 氢给体数:
    2
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933399090

SDS

SDS:15d5a10bfffae96f37834e4c86bc5128
查看

反应信息

  • 作为反应物:
    描述:
    3-(氯甲基)哌啶盐酸盐 在 sodium sulfite 作用下, 以 为溶剂, 反应 1.0h, 以88%的产率得到3-piperidinylmethanesulfonic acid
    参考文献:
    名称:
    Methods and compositions for treating amyloid-related diseases
    摘要:
    描述了用于治疗或预防与淀粉样蛋白相关疾病的方法、化合物、药物组合物和试剂盒。
    公开号:
    US20060223855A1
  • 作为产物:
    描述:
    3-哌啶甲醇盐酸氯化亚砜 作用下, 以 氯仿 为溶剂, 反应 1.0h, 以96%的产率得到3-(氯甲基)哌啶盐酸盐
    参考文献:
    名称:
    Methods and compositions for treating amyloid-related diseases
    摘要:
    描述了用于治疗或预防与淀粉样蛋白相关疾病的方法、化合物、药物组合物和试剂盒。
    公开号:
    US20060223855A1
点击查看最新优质反应信息

文献信息

  • Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist
    作者:Robert J. DeVita、Darius D. Hollings、Mark T. Goulet、Matthew J. Wyvratt、Michael H. Fisher、Jane-L. Lo、Yi Tien Yang、Kang Cheng、Roy G. Smith
    DOI:10.1016/s0960-894x(99)00446-1
    日期:1999.9
    Screening of the Merck sample collection for non-peptide compounds with binding affinity for the rat GnRH receptor led to the identification of the substituted quinolone (1) as a lead compound in the search for a non-peptide GnRH receptor antagonist. Substantial improvements in potency (similar to 300 fold) were achieved by addition of an alkyl amine at the 4-position, a 3,5-dimethylphenyl group at the 3-position and 6-nitro-7-chloro-substitution of the 1H-quinolone core. (C) 1999 Elsevier Science Ltd. All rights reserved.
  • 3-(Methyleneaminoxy)methylpiperidine derivatives as uptake inhibitors of biogenic amines in the brain synaptosomal fraction
    作者:A Balsamo、A Lapucci、A Lucacchini、M Macchia、C Martini、C Nardini、S Nencetti
    DOI:10.1016/0223-5234(94)90197-x
    日期:1994.1
    A series of 3-(methyleneaminoxy)methylpiperidines (5a-h) and their corresponding N-methyl derivatives (6a-h) with a variety of substituents on the imino carbon were synthesized and tested for their potential antidepressant properties; their capacity to inhibit the re-uptake of biogenic amines (NA, 5-HT and DA) in rabbit brain synaptosomal fractions was also evaluated. The biological results obtained for the piperidine derivatives 5a-h and 6a-h and viloxazine 1, the reference drug, on the 3 re-uptake systems revealed that compounds 5 and 6 are generally able to inhibit biogenic amine uptake. The IC50 values for 5 and 6 were often lower than that of viloxazine 1, in particular for the serotonin- and/or dopamine-uptake systems. A higher activity was found for compounds substituted with at least one phenyl ring on the imino carbon with respect to completely aliphatic systems, and for N-unsubstituted compounds with respect to N-methyl-substituted compounds.
  • Methods and compositions for treating amyloid-related diseases
    申请人:Kong Xianqi
    公开号:US20060223855A1
    公开(公告)日:2006-10-05
    Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.
    描述了用于治疗或预防与淀粉样蛋白相关疾病的方法、化合物、药物组合物和试剂盒。
查看更多